Full Text Journal Articles by
Author James C Ulchaker

Advertisement

Find full text journal articles






Reply by Authors.

Kevin T McVary, Marc C Gittelman, Kenneth A Goldberg, Kalpesh Patel, Neal D Shore, Richard M Levin, Marc Pliskin, J Randolf Beahrs, David Prall, Jed Kaminetsky, Barrett E Cowan, Christopher H Cantrill, Lance A Mynderse, James C Ulchaker, Nicholas N Tadros, Steven N Gange, Claus G Roehrborn,

J Urol (The Journal of urology)
[2021, :101097JU000000000000177803]

Cited: 0 times

View full text PDF listing >>



Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Kevin T McVary, Marc C Gittelman, Kenneth A Goldberg, Kalpesh Patel, Neal D Shore, Richard M Levin, Marc Pliskin, J Randolf Beahrs, David Prall, Jed Kaminetsky, Barrett E Cowan, Christopher H Cantrill, Lance A Mynderse, James C Ulchaker, Nicholas N Tadros, Steven N Gange, Claus G Roehrborn,

<h4>Purpose</h4>We present final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor therapy (Rezūm™) for treatment of moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia.<h4>Materials and methods</h4>A total of 197 subjects <u>></u>50 years of age with International Prostate Symptom Score ≥13, maximum flow ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000001778]

Cited: 0 times

View full text PDF listing >>



Advertisement

Comparative Effectiveness of Transurethral Prostate Procedures at Enabling Urologic Medication Discontinuation: A Retrospective Analysis.

Navin C Sabharwal, Daniel A Shoskes, Elodi J Dielubanza, James C Ulchaker, Khaled Fareed, Bradley C Gill,

<h4>Objective</h4>To test the hypothesis that transurethral prostate procedures (TUPPs) eliminating tissue result in greater medication discontinuation and lower de novo initiation rates than procedures inducing tissue necrosis.<h4>Methods</h4>Retrospective review of all men undergoing first time TUPPs at a large tertiary center from 2001 to 2016 was completed. Procedure type and urologic ... Read more >>

Urology (Urology)
[2019, 134:192-198]

Cited: 0 times

View full text PDF listing >>



EDITORIAL COMMENT.

James C Ulchaker,

Urology (Urology)
[2019, 134:202]

Cited: 0 times

View full text PDF listing >>



Cost Comparison of Benign Prostatic Hyperplasia Treatment Options.

Molly E DeWitt-Foy, Bradley C Gill, James C Ulchaker,

<h4>Purpose of review</h4>To provide an economic context within which to consider treatment options for benign prostatic hyperplasia (BPH). To this end, this review provides a comparison of the costs of combination medical therapy, operative treatment, and office-based therapies for BPH from a payer perspective.<h4>Recent findings</h4>Analysis of Medicare charges from the ... Read more >>

Curr Urol Rep (Current urology reports)
[2019, 20(8):45]

Cited: 1 time

View full text PDF listing >>



Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room.

Bradley C Gill, James C Ulchaker,

<h4>Purpose of review</h4>To review the costs associated with benign prostatic hyperplasia (BPH) management. Specifically, to compare the costs of medical therapy, office-based procedures, and surgical management from a payer perspective.<h4>Recent findings</h4>The American Urological Association released updated guidelines in 2018 for the surgical management of BPH. Over recent years, analyses investigating ... Read more >>

Curr Urol Rep (Current urology reports)
[2018, 19(9):72]

Cited: 2 times

View full text PDF listing >>



Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.

James C Ulchaker, Melissa S Martinson,

Objective:To conduct a cost-effectiveness analysis from payers' perspectives of six treatments for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) and to examine positioning of these modalities in the marketplace for the best use of health care funds and quality-of-life benefits for patients. Methods:The economic analysis was ... Read more >>

Clinicoecon Outcomes Res (ClinicoEconomics and outcomes research : CEOR)
[2018, 10:29-43]

Cited: 7 times

View full text PDF listing >>



Editorial Comment.

James C Ulchaker,

J Urol (The Journal of urology)
[2017, 198(5):1129]

Cited: 0 times

View full text PDF listing >>



Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.

Claus G Roehrborn, Steven N Gange, Marc C Gittelman, Kenneth A Goldberg, Kalpesh Patel, Neal D Shore, Richard M Levin, Michael Rousseau, J Randolf Beahrs, Jed Kaminetsky, Barrett E Cowan, Christopher H Cantrill, Lance A Mynderse, James C Ulchaker, Thayne R Larson, Christopher M Dixon, Kevin T McVary,

<h4>Purpose</h4>We report 2-year outcomes of a multicenter randomized controlled trial plus 1-year results of a crossover trial after treatment with convective radiofrequency water vapor thermal energy for lower urinary tract symptoms due to benign prostatic hyperplasia.<h4>Materials and methods</h4>A total of 197 men at least 50 years old with I-PSS (International ... Read more >>

J Urol (The Journal of urology)
[2017, 197(6):1507-1516]

Cited: 18 times

View full text PDF listing >>



Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study".

Kevin T McVary, Steven N Gange, Marc C Gittelman, Kenneth A Goldberg, Kalpesh Patel, Neal D Shore, Richard M Levin, Michael Rousseau, J Randolf Beahrs, Jed Kaminetsky, Barrett E Cowan, Christopher H Cantrill, Lance A Mynderse, James C Ulchaker, Thayne R Larson, Christopher M Dixon, Claus G Roehrborn,

J Sex Med (The journal of sexual medicine)
[2016, 13(6):936-937]

Cited: 0 times

View full text PDF listing >>



Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.

Kevin T McVary, Steven N Gange, Marc C Gittelman, Kenneth A Goldberg, Kalpesh Patel, Neal D Shore, Richard M Levin, Michael Rousseau, J Randolf Beahrs, Jed Kaminetsky, Barrett E Cowan, Christopher H Cantrill, Lance A Mynderse, James C Ulchaker, Thayne R Larson, Christopher M Dixon, Claus G Roehrborn,

<h4>Introduction</h4>Most surgical treatments for male lower urinary tract symptoms and benign prostatic hyperplasia affect erectile and ejaculatory functions negatively, leading to patient dissatisfaction.<h4>Aim</h4>To determine whether water vapor thermal therapy, when conducted in a randomized controlled trial, would significantly improve lower urinary tract symptoms secondary to benign prostatic hyperplasia and urinary ... Read more >>

J Sex Med (The journal of sexual medicine)
[2016, 13(6):924-933]

Cited: 22 times

View full text PDF listing >>



Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Kevin T McVary, Steven N Gange, Marc C Gittelman, Kenneth A Goldberg, Kalpesh Patel, Neal D Shore, Richard M Levin, Michael Rousseau, J Randolf Beahrs, Jed Kaminetsky, Barrett E Cowan, Christopher H Cantrill, Lance A Mynderse, James C Ulchaker, Thayne R Larson, Christopher M Dixon, Claus G Roehrborn,

<h4>Purpose</h4>This report reveals the results of a multicenter, randomized, controlled study using transurethral prostate convective water vapor thermal energy to treat lower urinary tract symptoms associated with benign prostatic hyperplasia.<h4>Materials and methods</h4>Men 50 years old or older with an International Prostate Symptom Score of 13 or greater, maximum flow rate ... Read more >>

J Urol (The Journal of urology)
[2016, 195(5):1529-1538]

Cited: 39 times

View full text PDF listing >>



Identification of the variables associated with pain during transrectal ultrasonography-guided prostate biopsy in the era of periprostatic nerve block: the role of transrectal probe configuration.

Ayman S Moussa, Ahmed El-Shafei, Ed Diaz, Tianming Gao, Osama M Zaytoun, Khaled Fareed, James C Ulchaker, J Stephen Jones,

<h4>Objective</h4>To identify the different factors that are associated with pain perceived during transrectal ultrasonography (TRUS)-guided prostate biopsy (PBx), with special focus on the role of transrectal probe configuration.<h4>Patients and methods</h4>We analysed prospective data on 1114 patients undergoing TRUS-guided PBx at our institute from January 2007 to August 2010. Patients completed ... Read more >>

BJU Int (BJU international)
[2013, 111(8):1281-1286]

Cited: 1 time

View full text PDF listing >>



Editorial comment.

James C Ulchaker,

Urology (Urology)
[2011, 78(1):145-6; author reply 146]

Cited: 0 times

View full text PDF listing >>



Prophylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study.

Samuel T Chao, Kenneth Angermeier, Eric A Klein, Chandana A Reddy, James C Ulchaker, Andrew Stephenson, Steven Campbell, Jay P Ciezki,

<h4>Purpose</h4>To study the feasibility/toxicity of urethral stenting with the Memokath<sup>®</sup> 028SW stent in patients undergoing prostate implant (PI) for prostate adenocarcinoma.<h4>Material and methods</h4>An Investigational Device Exemption from the Food and Drug Administration (FDA) and institutional review board (IRB) approval were obtained. Twenty patients enrolled. Baseline American Urological Association (AUA) score ... Read more >>

J Contemp Brachytherapy (Journal of contemporary brachytherapy)
[2011, 3(1):18-22]

Cited: 1 time

View full text PDF listing >>



Update on AUA guideline on the management of benign prostatic hyperplasia.

Kevin T McVary, Claus G Roehrborn, Andrew L Avins, Michael J Barry, Reginald C Bruskewitz, Robert F Donnell, Harris E Foster, Chris M Gonzalez, Steven A Kaplan, David F Penson, James C Ulchaker, John T Wei,

<h4>Purpose</h4>To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic hyperplasia (BPH).<h4>Materials and methods</h4>From MEDLINE® searches of English language publications (January 1999 through February 2008) using relevant MeSH terms, articles concerning the management of the index patient, a male ≥45 years of ... Read more >>

J Urol (The Journal of urology)
[2011, 185(5):1793-1803]

Cited: 437 times

View full text PDF listing >>



Editorial comment.

James C Ulchaker,

Urology (Urology)
[2009, 74(4):937; author reply 937]

Cited: 0 times

View full text PDF listing >>



Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer.

Carvell T Nguyen, David B Litt, Sandra E Dolar, James C Ulchaker, J Stephen Jones, Jennifer A Brainard,

<h4>Objectives</h4>To determine the outcomes for patients with nondiagnostic fluorescence in situ hybridization (FISH) (ie, < 4 gains of chromosomes 3, 7, or 17 in < or = 3 cells). FISH detects urothelial carcinoma and is especially beneficial in patients with negative or atypical urine cytology findings. A positive result is ... Read more >>

Urology (Urology)
[2009, 73(2):347-350]

Cited: 4 times

View full text PDF listing >>



Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.

Brian J Yoder, Marek Skacel, Ryan Hedgepeth, Denise Babineau, James C Ulchaker, Louis S Liou, Jennifer A Brainard, Charles V Biscotti, J Stephen Jones, Raymond R Tubbs,

A proportion of patients under surveillance for recurrent bladder carcinoma with no immediate evidence of bladder tumor recurrence have positive multitarget fluorescence in situ hybridization (FISH; UroVysion, Vysis, Downers Grove, IL) results. The course of these "anticipatory positive" cases and the time to bladder tumor recurrence remains unknown. We followed ... Read more >>

Am J Clin Pathol (American journal of clinical pathology)
[2007, 127(2):295-301]

Cited: 88 times

View full text PDF listing >>



Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis.

Ryan K Berglund, J Stephen Jones, James C Ulchaker, Amr Fergany, Inderbir Gill, Jihad Kaouk, Eric A Klein,

<h4>Objectives</h4>Locally advanced prostate cancer is frequently treated with radiotherapy and androgen deprivation because of the greater rate of extracapsular disease and the concern that radical prostatectomy (RP) may not be curative in most cases. A case for surgery for locally advanced disease may be made on the basis of a ... Read more >>

Urology (Urology)
[2006, 67(6):1253-1256]

Cited: 51 times

View full text PDF listing >>



Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.

Alexis E Te, Terrence R Malloy, Barry S Stein, James C Ulchaker, Unyime O Nseyo, Mahmood A Hai,

<h4>Unlabelled</h4>In a multicentre study from the USA, 3-year results of the high-power KTP laser prostatectomy are presented. The authors used preoperative PSA level as a marker of prostate volume and assessed its potential predictive value on the level of clinical efficacy for treating symptomatic BPH. They found that the overall ... Read more >>

BJU Int (BJU international)
[2006, 97(6):1229-1233]

Cited: 80 times

View full text PDF listing >>



A rare case of an extra-adrenal myelolipoma arising in the renal sinus: a case report and review of the literature.

Peter E Clark, Carol F Farver, James C Ulchaker, Kenneth Angermeier,

ScientificWorldJournal (TheScientificWorldJournal)
[2005, 5:109-117]

Cited: 3 times

View full text PDF listing >>



Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model.

Alireza Moinzadeh, Inderbir S Gill, Mauricio Rubenstein, Osamu Ukimura, Monish Aron, Massimiliano Spaliviero, Kester Nahen, Antonio Finelli, Cristina Magi-Galluzzi, Mihir Desai, Jihad Kaouk, James C Ulchaker,

<h4>Purpose</h4>Laparoscopic partial nephrectomy (LPN) with hilar clamping represents the various challenges associated with warm ischemia. We tested the feasibility, and acute and chronic outcomes of LPN using a potassium-titanyl-phosphate (KTP) laser without vascular hilar clamping in the survival calf model.<h4>Materials and methods</h4>Six Jersey calves weighing 76 to 94 kg underwent ... Read more >>

J Urol (The Journal of urology)
[2005, 174(3):1110-1114]

Cited: 31 times

View full text PDF listing >>



Prospective evaluation of interstitial laser coagulation of the prostate: importance of surgical technique and patient selection.

Christopher S Ng, James C Ulchaker, Elroy D Kursh,

<h4>Purpose</h4>To evaluate the impact of improvements in surgical technique and patient selection on overall outcomes of interstitial laser coagulation (ILC) of the prostate and to describe our treatment algorithm.<h4>Patients and methods</h4>During a 4-year period, 66 men with bothersome lower urinary-tract symptoms underwent ILC of the prostate using the Indigo 830e ... Read more >>

J Endourol (Journal of endourology)
[2005, 19(8):1012-1015]

Cited: 3 times

View full text PDF listing >>



Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.

Mohamed A Elshaikh, James C Ulchaker, Chandana A Reddy, Kenneth W Angermeier, Eric A Klein, Nabil Chehade, Andrew Altman, Jay P Ciezki,

<h4>Purpose</h4>To evaluate the effectiveness of prophylactic tamsulosin (Flomax) in reducing the urinary symptoms in patients undergoing 125I prostate implantation (PI) for prostate adenocarcinoma.<h4>Methods and materials</h4>This is a single-institution, double-blind, placebo-controlled, randomized trial for patients undergoing PI for prostate adenocarcinoma comparing prophylactic tamsulosin versus placebo. Eligibility criteria included patients not taking ... Read more >>

Int J Radiat Oncol Biol Phys (International journal of radiation oncology, biology, physics)
[2005, 62(1):164-169]

Cited: 33 times

View full text PDF listing >>



Advertisement

Disclaimer
1.0177 s